down arrow

Jubilant Pharmo

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE700A01033
  • NSEID: JUBLPHARMA
  • BSEID: 530019
INR
898.15
68.15 (8.21%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.33 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
1,821.70
1,752.30
1,731.70
1,758.60
1,677.10
1,680.30
1,586.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,821.70
1,752.30
1,731.70
1,758.60
1,677.10
1,680.30
1,586.90
Raw Material Cost
467.00
469.00
465.30
497.30
431.50
464.40
428.10
Purchase of Finished goods
81.20
69.30
61.80
53.90
71.80
58.40
57.10
(Increase) / Decrease In Stocks
26.20
16.50
34.60
-23.80
32.60
34.50
34.90
Employee Cost
560.10
564.30
552.90
555.00
581.50
531.80
547.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
399.80
343.80
365.60
404.80
341.70
349.40
349.50
Total Expenditure (Excl Depreciation)
1,534.30
1,462.90
1,480.20
1,487.20
1,459.10
1,438.50
1,417.30
Operating Profit (PBDIT) excl Other Income
287.40
289.40
251.50
271.40
218.00
241.80
169.60
Other Income
9.20
21.70
14.00
14.40
35.80
9.90
8.60
Operating Profit (PBDIT)
296.60
311.10
265.50
285.80
253.80
251.70
178.20
Interest
55.60
61.00
71.00
73.00
71.30
66.10
61.90
Exceptional Items
-18.90
-14.20
395.90
-168.90
0.00
0.00
0.00
Gross Profit (PBDT)
222.10
235.90
590.40
43.90
182.50
185.60
116.30
Depreciation
91.30
91.40
90.70
101.00
94.60
96.60
89.70
Profit Before Tax
130.50
144.40
499.70
-53.70
101.00
98.00
25.20
Tax
29.80
41.90
17.90
8.10
34.60
35.90
19.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
101.00
102.60
481.80
-65.20
53.30
53.10
7.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
101.00
102.60
481.80
-65.20
53.30
53.10
7.40
Share in Profit of Associates
-0.30
-0.10
0.00
3.40
13.10
9.00
-1.40
Minority Interest
-0.20
-0.30
-0.30
-3.20
-0.40
-0.40
-0.40
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
100.90
102.80
482.10
-58.60
66.80
62.50
6.40
Equity Capital
15.80
15.80
15.80
15.80
15.80
15.80
15.80
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
6.39
6.51
30.51
-3.71
4.23
3.96
0.41
Diluted Earnings per share
6.36
6.46
30.35
-3.68
4.2
3.94
0.4
Operating Profit Margin (Excl OI)
15.85%
16.61%
14.62%
15.54%
13.09%
14.51%
10.83%
Gross Profit Margin
12.25%
13.54%
34.32%
2.51%
10.96%
11.14%
7.42%
PAT Margin
5.55%
5.88%
28.01%
-3.54%
3.99%
3.73%
0.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2024 is 8.62% vs 8.03% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2024 is 51.05% vs 526.29% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is 31.83% vs 49.44% in Dec 2023

stock-summary

Interest

YoY Growth in quarter ended Dec 2024 is -22.02% vs 40.66% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023

Compare Quarterly Results Of Jubilant Pharmo With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,821.70
3,230.00
-1,408.30
-43.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,821.70
3,230.00
-1,408.30
-43.60%
Raw Material Cost
467.00
536.11
-69.11
-12.89%
Purchase of Finished goods
81.20
387.30
-306.10
-79.03%
(Increase) / Decrease In Stocks
26.20
11.81
14.39
121.85%
Employee Cost
560.10
709.71
-149.61
-21.08%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
399.80
755.27
-355.47
-47.07%
Total Expenditure (Excl Depreciation)
1,534.30
2,400.20
-865.90
-36.08%
Operating Profit (PBDIT) excl Other Income
287.40
829.80
-542.40
-65.37%
Other Income
9.20
77.32
-68.12
-88.10%
Operating Profit (PBDIT)
296.60
907.12
-610.52
-67.30%
Interest
55.60
220.93
-165.33
-74.83%
Exceptional Items
-18.90
0.00
-18.90
Gross Profit (PBDT)
222.10
686.19
-464.09
-67.63%
Depreciation
91.30
192.30
-101.00
-52.52%
Profit Before Tax
130.50
497.33
-366.83
-73.76%
Tax
29.80
112.81
-83.01
-73.58%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
101.00
381.08
-280.08
-73.50%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
101.00
381.08
-280.08
-73.50%
Share in Profit of Associates
-0.30
3.44
-3.74
-108.72%
Minority Interest
-0.20
4.29
-4.49
-104.66%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
100.90
380.23
-279.33
-73.46%
Equity Capital
15.80
40.06
-24.26
-60.56%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.39
9.49
-3.10
-32.67%
Diluted Earnings per share
6.36
9.44
-3.08
-32.63%
Operating Profit Margin (Excl OI)
15.85%
25.69%
0.00
-9.84%
Gross Profit Margin
12.25%
21.24%
0.00
-8.99%
PAT Margin
5.55%
11.90%
0.00
-6.35%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,821.70 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 3.96% vs 1.19% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 8.62% vs 8.03% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 100.90 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -1.85% vs -78.68% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 51.05% vs 526.29% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 287.40 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -0.69% vs 15.07% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 31.83% vs 49.44% in Dec 2023

Quarterly - Interest
Interest 55.60 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -8.85% vs -14.08% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -22.02% vs 40.66% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.85%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023